• SENSEX 76,835.78
    776.01 (+1.02%)
  • BANKNIFTY 57,087.20
    393.70 (+0.69%)
  • Infosys
    1,081.50 1,727.85(%)
  • Bluestone Jewel
    828.70 872.60(%)
  • Jubilant Food.
    428.40 670.65(%)
  • Laurus Labs
    1,734.25 1,734.25(%)
  • Swiggy
    264.45 473.00(%)
  • Eternal
    296.75 368.40(%)
  • Caliber Mining
    624.25 624.25(%)
  • Millworks Technologies
    802.50 802.50(%)
  • IDFC First Bank
    88.70 88.70(%)
  • Pidilite Inds.
    1,621.95 1,625.50(%)
  • Sun Pharma.Inds.
    1,977.00 1,977.00(%)
  • Navin Fluo.Intl.
    7,745.00 7,929.90(%)
  • KFin Technolog.
    954.85 1,217.20(%)
  • O N G C
    238.30 227.60(%)
  • Piramal Pharma
    192.60 210.35(%)
  • Cupid
    222.00 225.90(%)
  • TVS Motor Co.
    3,919.60 3,974.00(%)
  • SRF
    2,632.60 2,313.75(%)
  • Oracle Fin.Serv.
    11,189.35 11,986.90(%)
  • Bajaj Auto
    11,249.65 11,333.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ipca Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3617.0
  • ISIN : INE571A01038
1,777.60 15 (0.85%)
  • As on 27 Jul 2026 (EOD)

  • Today’s Low

    1,749.60

  • Today’s High

    1,800.00

  • Open

    1,762.70

  • Perv Close

    1,762.70

  • 52W Low

    1,251.60

  • 52W High

    1,944.90

Key Indicators

  • P/E(TTM)

    39.69

  • Mar.Cap (₹Cr.)

    45,098.46

  • Div & Yield %

    0.34

  • Book Value(₹)

    314.51

  • Debt-Equity Ratio

    0.85

  • AGM Date

    27-Jul-2026

  • EPS

    44.78

  • P/E Ratio

    39.69

Financials Ratios

  • Debt-Equity Ratio

    0.24

  • Mar.Cap (₹Cr.)

    45,098.46

  • RONW (%)

    8.69

  • ROCE (%)

    12.92

Score Board

  • Equity (₹ in Cr.)

    25.37

  • BV (₹)

    314.50

  • Sales( ₹ in Cr.)

    7,336.75

  • NP (in Cr.)

    1,135.98

  • NP Var(%)

    38.0

  • Div%

    600.0

  • CPS (₹)

    55.40

  • EPS (₹)

    44.80

  • Traded Value (₹ in Lakhs)

    45,089.58

  • 52 Week High

    1,944.90

  • 52 Week Low

    1,251.60

  • Price BSE

    1777.0

  • Price NSE

    1,778.00

  • Market Capital( in Cr.)

    45,089.58

  • P/C Ratio

    32.10

  • P/E Ratio

    39.70

  • Price Vs.BV

    44.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 7,336.75 6,677.92 6,166.46 5,814.62 5,438.30 5,139.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7,336.75 6,677.92 6,166.46 5,814.62 5,438.30 5,139.16
Other Income 94.64 71.29 111.29 111.19 52.92 62.24
Stock Adjustments 60.06 -128.43 55.19 -104.09 126.00 170.73
Total Income 7,491.45 6,620.78 6,332.94 5,821.72 5,617.22 5,372.13
EXPENDITURE :            
Raw Materials 1,916.84 1,764.88 2,033.57 1,964.94 1,911.88 1,753.21
Power and Fuel Cost 250.97 235.60 253.33 277.21 237.44 201.48
Employee Cost 1,655.90 1,479.34 1,336.19 1,193.39 1,102.14 948.84
Other Manufacturing Expenses 385.83 367.61 356.81 311.74 279.03 225.25
Selling and Administration Expenses 1,077.02 953.42 846.95 812.67 612.89 551.23
Miscellaneous Expenses 358.43 503.13 314.87 236.31 179.67 113.31
Employee Benefit Expenses 1,655.90 1,479.34 1,336.19 1,193.39 1,102.14 948.84
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,644.99 5,303.98 5,141.72 4,796.26 4,323.05 3,793.32
Operating Profit 1,846.46 1,316.80 1,191.22 1,025.46 1,294.17 1,578.81
Interest 45.46 65.06 122.58 46.34 10.41 11.13
Gross Profit 1,801.00 1,251.74 1,068.64 979.12 1,283.76 1,567.68
Depreciation 268.87 251.97 246.48 228.63 209.65 187.72
Profit Before Tax 1,532.13 999.77 822.16 750.49 1,074.11 1,379.96
Current Tax 402.12 340.90 288.01 223.95 197.28 244.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.51 8.11 3.74 20.84 16.46 -5.79
Reported Net Profit 1,132.52 650.76 530.41 505.70 860.37 1,140.77
Extraordinary Items -3.46 -169.55 -69.52 17.51 7.86 8.34
Adjusted Net Profit 1,135.98 820.31 599.93 488.19 852.51 1,132.43
Adjustment below Net Profit 3.35 -4.92 -1.39 -2.05 1.15 -0.16
P & L Balance brought forward 5,501.16 4,956.80 4,478.52 4,076.35 3,316.31 2,277.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 50.74 101.48 50.74 101.48 101.48 101.48
P & L Balance carried down 6,586.29 5,501.16 4,956.80 4,478.52 4,076.35 3,316.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 600.00 400.00 400.00 400.00 400.00 400.00
Dividend Per Share(Rs) 6.00 4.00 4.00 4.00 4.00 8.00
Earnings Per Share-Unit Curr 44.64 25.65 20.91 19.93 33.91 89.93
Earnings Per Share(Adj)-Unit Curr 44.64 25.65 20.91 19.93 33.91 44.97
Book Value 314.52 271.64 250.24 231.66 215.84 374.67
Book Value(Adj)-Unit Curr 314.52 271.64 250.24 231.66 215.84 187.34

Shareholding Pattern

  • Promoter Group

    44.72%

  • Public Share Holding

    55.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 95,423,418 37.61 95,423,418 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,044,054 7.11 18,044,054 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 113,467,472 44.72 113,467,472 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,130 0.00 130 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 8,000 0.00 0 1
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,210,576 10.73 27,210,576 189
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,301,096 5.24 13,301,096 11
Mutual Funds / UTI 79,037,288 31.15 79,033,288 33
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,464,676 0.97 2,464,676 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 122,023,766 48.10 122,009,766 256
2] Non Institution
Bodies Corporate 857,826 0.34 853,826 532
Clearing Members 46,975 0.02 46,975 32
Directors of their Relatives 42,000 0.02 42,000 1
Employees 23,000 0.01 0 10
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 8,000 0.00 8,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 938,122 0.37 936,130 2,751
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 722,063 0.28 720,063 1,283
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 14,622,148 5.76 14,022,694 77,103
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 16,889 0.01 16,889 7
Others 825,331 0.33 825,331 2
Sub Total 18,212,980 7.18 17,582,534 81,790
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 253,704,218 100.00 253,059,772 82,060

Company Background

Ipca Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ipca Laboratories Ltd
  • BSE Code : 3617.0
  • ISIN : INE571A01038

  • Incorporation Year

    1949

  • Registered Office

    48 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474444

  • FAX

    91-22-28686613

  • Chairman

    Premchand Godha

  • Managing Director

    A K Jain

  • Company Secretary

    Harish P Kamath

  • Auditor

    NVC & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ipca Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ipca Labs. 1,777.25 7,431.39 7,336.75 39.81 19.48
Abbott India 27,813.40 7,217.19 6,929.05 38.08 43.78
Astrazeneca Phar 8,167.90 2,304.07 2,275.58 108.89 27.86
P & G Health Ltd 6,781.40 944.52 934.17 34.43 71.75
Glaxosmi. Pharma 2,550.20 3,932.76 3,790.20 42.70 58.17
Cipla 1,409.85 20,102.60 18,979.95 37.05 13.88
Amrutanjan Healt 513.60 469.50 451.82 25.64 21.89
Bliss GVS Pharma 461.00 773.53 729.81 50.49 12.51
Fermenta Biotec. 444.00 474.15 450.25 20.33 18.77
Guj. Themis Bio. 360.65 152.47 150.80 84.26 27.21
Ambalal Sarabhai 31.80 19.52 3.94 22.24 6.77